Illumina Launches TruGenome Undiagnosed Disease Test

Product News   Oct 28, 2013

 
Illumina Launches TruGenome Undiagnosed Disease Test
 
 
FURTHER INFORMATION
 

Related Product News

Cambridge Epigenetix Licenses Fundamental DNA Methylation IP from Boston Children’s Hospital

Product News

The exclusive licence enables the development and commercialisation of 5hmC technologies for epigenetic biomarker discovery.

READ MORE

OGT’s Expanded NGS Cancer Panels Enable Sequencing of Difficult Genes

Product News

New SureSeq myPanel™ NGS Custom Cancer Panel content covers a wider range of cancer types with excellent coverage uniformity for confident results.

READ MORE

llumina Launches the VeriSeq™ NIPT Solution in Europe

Product News

NGS-based solution makes fast, highly accurate, cost-effective noninvasive prenatal testing available to EU labs.

READ MORE

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE